Nanjing Yoke Biotechnology

Nanjing Yoke Biotechnology is a China-based pharmaceutical company specializing in the research, development, and commercialization of anti-infective, cardiovascular, and oncological therapies. Founded in 2006, the company has established a robust portfolio of high-end generic drugs and is increasingly focusing on Class 1 innovative drug development. Their core expertise lies in the production of advanced cephalosporin antibiotics and other injectable medications. Nanjing Yoke operates integrated R&D and manufacturing facilities, maintaining a significant presence in the domestic Chinese hospital market. The company is recognized as a National High-tech Enterprise and continues to expand its pipeline with improved new drugs and novel chemical entities.